|
SARS-CoV-2
infection
n = 171
|
SARS-CoV-2 pneumonia
n = 127
|
Age, year |
80 (72–86) |
80 (72–85) |
Gender, male (%) |
112 (65.5) |
77 (60.6) |
Laboratory test |
|
|
N gene
Ct
value |
30 (27–34) |
30 (26–33) |
ORF gene Ct value |
33 (29–36) |
33 (28–36) |
Neutrophil,
×109/L
|
7.5 (5.4–10.4)
|
7.9 (5.5–10.8)
|
Lymphocyte,
×109/L |
0.8 (0.5–1.0) |
0.7 (0.4–1.2) |
NLR |
9.9 (5.1–18.4) |
10.9 (5.9–19.8) |
Hemoglobin,g/L |
112 (92–129) |
109 (92–129) |
Thrombocyte,
×109/L |
177 (138–256) |
177 (121–256) |
CRP, mg/dL |
19.7 (0.6–47.6) |
26 (5.8–48.4) |
D-Dimer, mg/L |
2.2 (0.6–6.0) |
2.5 (0.8–6.8) |
FiO2
|
0.8 (0.4–1.0) |
0.6 (0.6–1.0) |
PaO2, mmHg |
88 (70.7–103.1) |
90
(69.6–103) |
PF ratio, mmHg |
158 (122.7–253.9) |
146.7
(112.7–176.6) |
PaCO2, mmHg |
38.6 (34.5–56.1) |
39
(33–52.7) |
Quantitative CT analysis |
|
|
Total lung volume, ml |
3088 (2287-3808) |
2874
(2274–3644) |
GGO
volume, ml |
833 (654.5–10) |
1480 (907.5–2280) |
GGO ratio (%) |
30.3 (21.1–40.3) |
54 (40–63.5) |
Consolidation volume, ml |
186 (128.5–315.5) |
236
(154–349) |
Consolidation ratio (%) |
7.2 (3.8–9.7) |
8.8
(4.5–14.5) |